Overall Technical outlook

Price Summary

GlaxoSmithKline Pharmaceuticals Limited's stock opened at 2741.0 on 2025-10-17, surged to 2750.7, dropped to 2708.4, and ended 0.07% higher at 2742.9, with 53427 shares traded.
In the 52-week period, the stock's peak price is 3466.2, and the lowest price recorded is 1956.2.
According to 4 analysts, the future price is anticipated to vary between 2600.0 and 3500.0, with an average expected price of around 3094.75.

Technicals

Support and Resistance: The current price is 2742.9, with support at 2588.7 and resistance at 2759.9. This range suggests that the price might move between these levels, with 2588.7 offering support and 2759.9 capping further gains for GlaxoSmithKline Pharmaceuticals Limited.
GLAXO supportResistance 222f82
Support/Resistance for GLAXO


Aroon: The current reading of the AROON indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
GLAXO aroon 222f82
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, with no definitive indication of an upward or downward trend for GLAXO. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLAXO bbands 222f82
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help maintain the market's upward movement. This strong support suggests that the market is poised to continue its positive trend, providing confidence in the ongoing bullish momentum.
GLAXO psar 222f82
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: The STOCHASTIC is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
GLAXO stoch 222f82
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: The 20-50-100 period moving averages are positioned for a bullish trend, but the slopes of the faster averages hint at a possible trend reversal. While the overall outlook remains positive, the weakening momentum in the shorter-term averages suggests that the current trend might not hold for long.
GLAXO trippleSMA 222f82
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


A company's technical data, including stock price and trading volume, can provide valuable insights when considered alongside its fundamentals. These include financial performance, market share, and growth strategy, as well as broader industry dynamics. Examining these factors helps investors or analysts make more informed decisions, as the company's fundamentals offer context for understanding how and why certain technical patterns may emerge in the market.